Skip to main content
BMC Geriatrics logoLink to BMC Geriatrics
. 2011 Aug 24;11(Suppl 1):A26. doi: 10.1186/1471-2318-11-S1-A26

Quid novi in the eldery patient’s anesthesia

B Lettieri 1,, ML Mingione 1, A d’Elia 1, P Capodanno
PMCID: PMC3194352

Background

Today the availability of new local anesthetics and the use of analgesics, allow the modulation of the analgesia, maintaining a state of consciousness.

An answer to the needs of patients >75 years undergoing surgery is the technique Monitored Anesthesia Care (MAC), defined “the middle land” (Figure 1).

Figure 1.

Figure 1

Monitored anestesia care

MAC allows:

- the modulation of the level of analgesia at different stages of surgery due to the availability of analgesic action, but with rapid onset-time

- the additional analgesia using local anesthetics with prolonged effect without the use of noradrenaline, dangerous for elderly patients

the consciousness and cooperation of the patient (Table 1).

Table 1.

MAC.

Conscious Sedation ( MAC ) Unconscious Sedation
Altered consciousness Unconsciousness
Conscious patient Unconscious patient
Protective reflexes intact and active Protective reflexes decreased; airway obstruction may occur
Ventilation: hypoxia, hypercapnia
Cardiovascular system: , hypotension, hypertension, bradycardia, tachycardia
Stable vital signs Unstable vital signs
Analgesia may be present; need for regional analgesia / local or systemic Pain controlled centrally; does not require regional analgesia
Limited stay in the units of observation Requiring hospitalization or prolonged hospitalization
Low risk of complications High risk of complications
Infrequent postoperative complications Frequent postoperative complications
Patients with psychiatric problems or mental deficiency may be difficult to manage May be needed to manage patients with mental deficiency

Materials and methods

With this study we tested the efficacy, safety and limitations of the MAC.

The design of the study was a prospective, double-blind, parallel-group, with 42 patients randomly selected from 87 patients recruited between those eligible for inclusion in the circuit one-day surgery (Table 2)

Table 2.

Patients’ criteria of homogeneity.

Patients’ criteria of homogeneity
same level of gravity ASA II/III
NYHA II class
same duration of surgery (40 min ± 10 min

Two groups were subjected to two different regimes of sedation with propofol and midazolam, pain controlled with remifentanil.

- Primary end-point was verifying the level and quality of sedation achieved

- Secondary end-point was identifying and quantifying potential adverse effects (Table 3-4)

Table 3.

Access Criteria.

ACCESS CRITERIA
Weight 69 ± 6 Kg
Informed consent for MAC procedures
ASA II/III with stabilized cardio-circulatory impairments and respiratory parameters: pO2 ≤ 70 e pCO2 < 45 mmHg
Patients undergoing operations can be managed only with the cooperation of the patient
Age > 75 years

Table 4.

Exclusion Criteria.

EXCLUSION CRITERIA
Patient desire
ASA III impairment of vital organs in acute and evolutionary phase
Patients with unexpected rapid intubation
Patients with high risk of bleeding
Severe neurological disorders

Levels of sedation, pain and mental status were assessed using different clinical approaches :

- Observational data (Table 5).

Table 5.

Observer’ s assessment of alertness/sedation scale (oaa/s scale).

Answer Verbal expression Facial expression Eyes
Ready to the call, normal tone Normal Normal Normal 5
Torpid to the call, normal tone Initial slowdown Medium relaxation Medium relaxation 4
Only for repeat calls with high tone slowdown Marked relaxation Marked ptosis 3
Only if shaken Not understandable words --- --- 2
No answers, even if shaken --- --- --- 1

We proceeded as follows:

1) O2 inhalation (SpO2 > 98 and normocapnia)

2) during surgical manipulation a continuous infusion of remifentanil: 0.03 to 0.06 mg / kg / h was activated

Patients were randomly dichotomized into two arms with two different infusion regimens:

-group P (45 patients): starter bolus of 0.5 mg / kg propofol (to fill the central compartment) → P infusion of 1-2 mg / kg / h (to offset the rapid deployment)

-group M (41 patients): bolus starter from 0.03 to 0.05 mg / kg midazolam (average dose of 2-4 mg) infusion of 1-2 mg / kg / h

Every 10 m’ scores are recorded, BIS and OAA / S scale.

- objective parameters based on Ramsay Scale (Table 6).

Table 6.

Ramsay Scale.

1 Patient anxious and agitated or restless, or both
2 Patient co-operative, orientated and tranquil
3 Patient responds to commands only
4 Brisk response to a light glabellar tap or auditory stimulus
5 Sluggish response to a light glabellar tap or auditory stimulus
6 No response to the stimuli mentioned in items 4 and 5

- Instrumental response with Bispectral Index (Table 789)

Table 7.

Average values of clinical and instrumental group P.

T10m T20m T30m T40m
BIS 72 (42-45) 66 (35-88) 70 (55-82) 74 (52-88)
OAA/S 4 (1-5) 3-4 (1-5) 3-4(1-5) 4 (1-5)

Table 8.

Average values of clinical and instrumental group M.

T10m T20m T30m T40m
BIS 64 (48-86) 58 (35-73) 62 (36-84) 66 (48-83)
OAA/S 4 (1-5) 3-4 (1-5) 3-4 (1-5) 4 (1-5)

Table 9.

Propofol, Midazolam, Remifentanil during MAC.

Propofol Midazolam Remifentanil
onset of sedation rapid moderate rapid
resolution pharmacological effects rapid lenta rapid
injection pain yes no no
intraoperative and postoperative pain moderate moderate minimum
hemodynamic depression moderate minimum minimum
respiratory variations mild desaturation (<30%) minimum moderate
PONV minimum minimum minimum

Conclusions

The combination midazolam-remifentanil presented a lower synergistic effect compared with propofol-remifentanil. The first fact documented a mean BIS of 62.5 +3 vs. 64.7 +4 midazolam-remifentanil association and has finally, although sporadic, incidents of desaturation content and never > 30%. The evaluation of the kinetic values of BIS, the interesting fact that emerges concerns the values> 70, which represented a significant predictor in the study to better recovery of consciousness, which has helped the fast-traking ongoing day-surgery.

References

  1. Kenny DN. Patient sedation: technical problems and developements. Eur J Anesth. 1996;13:18–21. doi: 10.1097/00003643-199607001-00005. discussion 22-5. [DOI] [PubMed] [Google Scholar]
  2. Liu J, Singh H, White PF. EEG: BIS correlates with intraoperative recall and depth of propofol induced sedation. Anesth Analg. 1997;84(1):185–9. doi: 10.1097/00000539-199701000-00033. [DOI] [PubMed] [Google Scholar]
  3. Dexter F, Aker J, Wright WA. Development of a measure of patient satisfaction with monitored anesthesia care:the Jawa Satisfaction with Anesthesia Scale. Anesthesiology. 1997;87(4):865–73. doi: 10.1097/00000542-199710000-00021. [DOI] [PubMed] [Google Scholar]
  4. Murdoch JA, Hyde RA, Kenny GN. Target-controlled remifentanyl in combination with propofol for spontaneously breathing day-care patients. Anaesth. 1999;54(11):1028–31. doi: 10.1046/j.1365-2044.1999.00951.x. [DOI] [PubMed] [Google Scholar]
  5. Rego JA, White MM. What is new in monitored anesthesia care? Anesth. 1998;11:601–6. doi: 10.1097/00001503-199811000-00003. [DOI] [PubMed] [Google Scholar]
  6. Corck RC, Guillory EA. Effect of patient –controlled sedation on recovery from ambulatory monitored anesthesia care. An J Anesth. 1995;22(2):94–100. [PubMed] [Google Scholar]
  7. Twersy SR. The ambulatory anesthesia handbook. St. Louis, Ed.Mosby. 1997.

Articles from BMC Geriatrics are provided here courtesy of BMC

RESOURCES